MSC for Treatment of Interstitial Lung Disease After Allo-HSCT

NCT02543073 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators